Plain-English translation of NCT06962033 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether expanding opioid agonist therapy (a proven medication treatment for opioid addiction) in prisons, detention centers, and probation systems can help prevent HIV and improve health outcomes. The study works with healthcare providers, probation officers, and people in the criminal justice system across four countries to make this treatment more available and help people stay connected to care after release.
Many people with opioid addiction cycle through prisons and probation without access to effective treatment, which increases their risk for HIV and overdose. This study aims to solve that problem by helping criminal justice systems adopt this medication as part of routine care.
You likely qualify if…
You likely don't qualify if…
Depending on your role, you might complete surveys every 6 months about opioid treatment programs, participate in focus group discussions, or be interviewed about your experiences with treatment access. If you work at a probation site, you may be asked about how the program is working and what barriers exist. The study takes place in prisons, detention centers, and probation offices in Kyrgyzstan, Tajikistan, Moldova, and Georgia.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
United States
Georgia
Kyrgyzstan
Moldova
Tajikistan